New York State Teachers Retirement System Buys Shares of 28,300 ZimVie Inc. (NASDAQ:ZIMV)

New York State Teachers Retirement System bought a new stake in ZimVie Inc. (NASDAQ:ZIMVGet Rating) during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 28,300 shares of the company’s stock, valued at approximately $279,000. New York State Teachers Retirement System owned 0.11% of ZimVie at the end of the most recent quarter.

Several other hedge funds have also recently added to or reduced their stakes in ZIMV. US Bancorp DE acquired a new position in ZimVie in the third quarter valued at about $36,000. Strs Ohio acquired a new stake in shares of ZimVie during the third quarter worth about $47,000. Allspring Global Investments Holdings LLC acquired a new stake in shares of ZimVie during the third quarter worth about $71,000. Louisiana State Employees Retirement System acquired a new stake in shares of ZimVie during the third quarter worth about $99,000. Finally, Raymond James & Associates acquired a new stake in shares of ZimVie during the third quarter worth about $110,000. Institutional investors and hedge funds own 74.29% of the company’s stock.

Wall Street Analysts Forecast Growth

Separately, Barclays assumed coverage on ZimVie in a research report on Wednesday, December 21st. They set an “underweight” rating and a $9.00 price target on the stock.

ZimVie Stock Performance

NASDAQ ZIMV opened at $8.46 on Friday. The company has a quick ratio of 1.48, a current ratio of 2.51 and a debt-to-equity ratio of 0.76. The stock’s 50-day moving average is $9.01 and its 200-day moving average is $12.04. ZimVie Inc. has a one year low of $6.67 and a one year high of $50.40.

ZimVie (NASDAQ:ZIMVGet Rating) last announced its earnings results on Wednesday, November 9th. The company reported $0.49 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.27 by $0.22. ZimVie had a negative return on equity of 2.75% and a negative net margin of 9.96%. The business had revenue of $214.58 million for the quarter, compared to analyst estimates of $214.83 million. On average, equities research analysts anticipate that ZimVie Inc. will post 1.95 earnings per share for the current fiscal year.

ZimVie Company Profile

(Get Rating)

ZimVie Inc, a medical technology company, develops, manufactures, and delivers a portfolio of products and solutions designed to treat a range of spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It offers dental implant systems, prosthetic and abutment products, surgical instrumentation, and kits; bone grafts, barrier membranes, allografts, and collagen wound care products; intraoral scanners; and virtual treatment planning services, guided surgery solutions, CAD/CAM workflow systems, and patient-specific restorative components and intra-oral scanners, as well as spinal fusion implants and instrumentation for various spinal procedures, biologics, and bone healing technologies.

Recommended Stories

Institutional Ownership by Quarter for ZimVie (NASDAQ:ZIMV)

Receive News & Ratings for ZimVie Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ZimVie and related companies with MarketBeat.com's FREE daily email newsletter.